Nuveen Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
$4.85M Buy
134,127
+903
+0.7% +$32.7K ﹤0.01% 1999
2024
Q3
$4.15M Hold
133,224
﹤0.01% 2074
2024
Q2
$3.56M Sell
133,224
-93,808
-41% -$2.51M ﹤0.01% 2107
2024
Q1
$7.74M Buy
227,032
+96,301
+74% +$3.28M ﹤0.01% 1753
2023
Q4
$3.78M Sell
130,731
-99,861
-43% -$2.89M ﹤0.01% 2106
2023
Q3
$6.36M Sell
230,592
-57,714
-20% -$1.59M ﹤0.01% 1744
2023
Q2
$8.67M Sell
288,306
-138,674
-32% -$4.17M ﹤0.01% 1597
2023
Q1
$15.5M Buy
426,980
+8,085
+2% +$293K 0.01% 1211
2022
Q4
$14.9M Buy
418,895
+45,386
+12% +$1.62M 0.01% 1229
2022
Q3
$12.6M Buy
373,509
+18,950
+5% +$641K 0.01% 1338
2022
Q2
$10.3M Sell
354,559
-159,833
-31% -$4.62M ﹤0.01% 1491
2022
Q1
$16M Sell
514,392
-242,239
-32% -$7.55M 0.01% 1332
2021
Q4
$21.1M Buy
756,631
+199
+0% +$5.54K 0.01% 1203
2021
Q3
$20.6M Buy
756,432
+290,359
+62% +$7.92M 0.01% 1252
2021
Q2
$14.4M Buy
466,073
+172,875
+59% +$5.32M ﹤0.01% 1625
2021
Q1
$7.68M Buy
293,198
+824
+0.3% +$21.6K ﹤0.01% 1939
2020
Q4
$7.36M Sell
292,374
-4,316
-1% -$109K ﹤0.01% 1884
2020
Q3
$6.18M Sell
296,690
-32,107
-10% -$669K ﹤0.01% 1804
2020
Q2
$7.81M Buy
328,797
+12,943
+4% +$307K ﹤0.01% 1656
2020
Q1
$5.68M Buy
315,854
+16,431
+5% +$296K ﹤0.01% 1638
2019
Q4
$7.1M Sell
299,423
-335,068
-53% -$7.95M ﹤0.01% 1794
2019
Q3
$17.4M Buy
634,491
+323,879
+104% +$8.9M 0.01% 1214
2019
Q2
$10.3M Buy
310,612
+298,624
+2,491% +$9.88M ﹤0.01% 1591
2019
Q1
$420K Buy
11,988
+4,319
+56% +$151K ﹤0.01% 863
2018
Q4
$255K Sell
7,669
-5,796
-43% -$193K ﹤0.01% 924
2018
Q3
$678K Sell
13,465
-14,999
-53% -$755K ﹤0.01% 808
2018
Q2
$1.7M Buy
28,464
+7,051
+33% +$422K 0.01% 635
2018
Q1
$981K Buy
+21,413
New +$981K 0.01% 750
2017
Q1
Sell
-25,105
Closed -$634K 1452
2016
Q4
$634K Buy
+25,105
New +$634K ﹤0.01% 1247